DNA-based vaccine with genes coding for two HIV proteins: Began a Phase I/II trial of safety in 15 people who will receive an initial injection at one of three

Apollon Inc., Malvern, Penn. Product: DNA-based vaccine with genes coding for two HIV proteins Indication: Delay onset of AIDS in asymptomatic HIV-positive people Status: Began a Phase I/II trial of s...